Early detection.
Early treatment.
Improved quality of life.
What Makes Us Different?
At NeuroFore, we focus on the critical period before motor symptoms of Parkinson's emerge—a crucial time window traditionally overlooked by existing diagnostic methods. Our unique AI-driven approach evaluates subtle, early non-motor symptoms, delivering accurate and actionable results long before irreversible damage occurs. By emphasizing early detection and precision, NeuroFore sets a new benchmark in Parkinson’s disease diagnostics, enabling timely interventions and enhancing patient outcomes.
Mission
NeuroFore is here to bridge the diagnostic gap — using AI-driven analysis of subtle, early non-motor symptoms to identify Parkinson’s years before traditional methods can. We aim to empower healthcare providers, patients, and researchers with tools for earlier intervention, better outcomes, and a new standard of Parkinson’s care.
Team Culture
At NeuroFore, our team is united by a deep commitment to enhancing lives through innovation. Our story began with witnessing firsthand the profound impact Parkinson's disease has on patients and families. We are driven by empathy, precision, and innovation, fostering an inclusive culture of collaboration and continuous learning. We celebrate curiosity, welcome challenges, and work relentlessly to translate groundbreaking research into tangible clinical outcomes.
Hamasa Ebadi
Founder & CEO
Hamasa is a nationally recognized leader at the intersection of neuroscience, neuroethics, and medical innovation. She earned her Master’s degree in Bioethics & Medical Humanities with a concentration in Neuroethics from Case Western Reserve University, equipping her with a rare foundation in both the science and ethics of emerging neurotechnologies. She was involved in the development of the ethical framework for the first-in-human cortical prosthesis trial, setting new standards for how invasive neurotechnologies are evaluated, and later spearheaded digital health clinical transforming care for patients worldwide. Her scholarship has been published in top journals, and she is a sought-after speaker on the global stage—presenting at the NIH BRAIN Initiative and the International Neuroethics Society, and serving as keynote speaker for the American Society for Bioethics & Humanities.
Her achievements include an NIH BRAIN Initiative Challenge Award and multiple best abstract prizes, reflecting both her scientific rigor and her translational vision. In addition to her research and policy contributions, Hamasa has demonstrated exceptional entrepreneurial acumen—founding and scaling ventures that bridge cutting-edge neuroscience with real-world patient care. She brings a proven ability to move ideas from concept to clinic, navigating the complexities of innovation, regulation, and commercialization with uncommon skill. Hamasa’s motivation to improve neurological care is both personal and professional: born into a family of physicians, she developed a lifelong commitment to patient-centered healthcare. Under her guidance, NeuroFore is uniquely positioned to deliver an AI-driven Parkinson’s detection platform that is technically groundbreaking, clinically impactful, and ethically trustworthy.
Miles Gilliam
COO & Regulatory Lead
Miles is an accomplished neuroscientist and clinical trial leader with a proven record of advancing research programs from discovery to large-scale human trials. A graduate with honors in Neuroscience from Johns Hopkins University, he has led government-funded and industry-sponsored studies at UCSF, USC, and the University of Maryland School of Medicine, while also directing complex programs and building scalable operational frameworks at global leaders in life sciences and clinical research, including MilliporeSigma and Syneos Health. His expertise spans protocol development, IRB management, FDA regulatory compliance, and operational leadership—making him a pivotal force in translating innovation from bench to bedside. His career includes contributions across neurodegeneration, traumatic brain injury, Alzheimer’s disease, and critical care outcomes, and he has led international clinical studies that strengthened standards for recruitment, data integrity, and outcome measurement.
At NeuroFore, Miles leads clinical development strategy—shaping the regulatory and operational roadmap that will carry the AI-driven Parkinson’s detection platform through clinical validation and toward widespread adoption.
Advisory Board
Joseph Klaesner, PhD
Dr. Klaesner is an Associate Professor at Washington University School of Medicine with over 25 years of experience in medical device innovation, SBIR-funded research, and technology commercialization. Recognized as one of St. Louis’s Top 30 Innovators, he brings to NeuroFore deep expertise in translating engineering solutions into clinical practice and guiding startups to successful commercialization.
Daniel G. Di Luca, MD, MSc
Dr. Di Luca is an Assistant Professor of Neurology in the Division of Movement Disorders at Washington University in St. Louis. His expertise spans Parkinson’s disease, deep brain stimulation, dystonia, tremor, Huntington’s disease, ataxia, and atypical parkinsonian syndromes. He draws on his patient care and research expertise to ensure NeuroFore’s platform delivers meaningful value to both patients and physicians.
Meet the Team
Joe
Joe is studying Business, Computer Science, and Psychological & Brain Sciences at Washington University in St. Louis. An emerging leader in healthcare innovation with a proven track record in start-ups, he leads NeuroFore’s business strategy by leveraging his entrepreneurial experience to strengthen partnerships and accelerate the company’s path to market.
Evan
Evan is pursuing a graduate degree in Accounting at Washington University’s Olin Business School with a strong passion for startups and innovation. She brings a proven track record in organizational leadership to NeuroFore’s operations and communications. Driven by a commitment to helping Parkinson’s patients and their families, she is focused on advancing meaningful impact through her work.
Gemechu
Gemechu holds both an M.Sc. and a B.Sc. in Bio and Brain Engineering from the Korea Advanced Institute of Science and Technology (KAIST), with deep expertise in applying machine learning to brain data. He brings proven expertise in algorithm development and AI for neurological disease detection, ensuring the robustness and scalability of NeuroFore’s Parkinson’s detection platform.
Hayden
Hayden is studying Biomedical Engineering at Washington University in St. Louis and leads NeuroFore’s scientific review team. He ensures the platform’s scientific rigor by guiding the integration of validated scientific findings directly into NeuroFore’s development process.
Alicia
Alicia is studying Healthcare Management and Biology at Washington University in St. Louis. Passionate about preventive care and health marketing, she brings a proven track record in communications strategy to NeuroFore’s brand and media efforts, shaping clear, impactful messaging that strengthens engagement with both patients and physicians.
Kanishk
Kanishk is studying Neuroscience and Computer Science at Washington University in St. Louis. As a Scientific Review Associate with NeuroFore, he contributes to ensuring the accuracy and rigor of the company’s scientific foundation.
Channah
Channah is studying Philosophy-Neuroscience-Psychology and Healthcare Management at Washington University in St. Louis. She brings hands-on experience in healthcare entrepreneurship through Sling Health and contributes to NeuroFore’s business strategy with a focus on advancing innovative product development.
Carolyn Cameranesi
Carolyn is studying Finance and Healthcare Management at Washington University’s Olin Business School. An emerging leader in business strategy and healthcare innovation, she applies strategic, organizational, and financial insights to advance transformative solutions in medicine.
Ankush
Ankush is studying Neuroscience on the pre-med track at Washington University in St. Louis. With a strong background in scientific research and healthcare advocacy, he supports NeuroFore’s scientific review efforts by synthesizing evidence from research articles and leading outreach efforts.
Adrianna
Adrianna is studying Biomedical Engineering at Washington University in St. Louis. An emerging leader in healthcare innovation, she applies engineering solutions to advance technology in medicine and is active in the Society of Women Engineers and Engineers Without Borders. She brings this passion for innovation to NeuroFore’s product development efforts, helping to develop the device to drive transformative solutions for patients.